# Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

> **NCT00333684** · PHASE2 · COMPLETED · sponsor: **Canadian Immunodeficiency Research Collaborative** · enrollment: 36 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Facial Lipoatrophy

## Interventions

- **DEVICE:** BIO-ALCAMID SOFT TISSUE ENDOPROSTHESIS

## Key facts

- **NCT ID:** NCT00333684
- **Lead sponsor:** Canadian Immunodeficiency Research Collaborative
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-11
- **Final completion:** 2010-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333684, "Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00333684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*